diabetes complications Flashcards
main cause of hospitalization/mortality in diabetes
cardiovascular disease. Plus, diabetics do worse after MI
List macrovascular complications of diabetes
Increased risk of cardiovascular disease ( MI, stroke, peripheral vascular dz), heart failure
therapy to decrease cardiovascular complications of diabetes
lipid lowering and intensive blood pressure control
hypertension in diabetes
Very common in T2D and uncommon in T1D prior to onset of renal disease, although in T1D there is a loss in normal nocturnal lowering of BP
Diabetes and metabolic syndrome
Hyperinsulinemia is associated with the metabolic syndrome. This controversial syndrome is a constellation of: insulin resistance, visceral adiposity, hypertension, dyslipidemia, and type 2 diabetes/glucose intolerance. These factors all increase risk of macrovascular disease
lipid abnormalities in diabetes
hypertriglyceridemia, decreased HDL, altered lipoprotein composition, glycation/oxidation, small dense LDL
how does diabetes affect vascular wall response
- Abnormal endothelial cell function. 2. abnormal vascular smooth muscle function. 3. inflammation and decreased fibrinolysis
how does diabetes affect endothelial cell function
abnormal clotting (decreased tPA and increased PAI-1), inflammation, decrased vasomotion, increased cytokines/chemokines
how does diabetes affect vascular smooth muscle
enhances smooth muscle proliferation, increased production of matrix proteins, cytokines and growth factors, altered contractile function
How does diabetes affect inflammation/fibrinolysis
platelet adhesion and activation, monocyte adhesion/activation, foam cel formation
Interventions to decrease cardiovascular risk in diabetes
Beta blockers, antihypertensives and lipid lowering agents have great outcome. Aspirin has less of an impact in diabetes, but should be used in high risk subjects and people with diabetes and established CVD. Early intensive glycemic control
List mechanisms of microvascular complications in diabetes
Polyol pathways, non-enzymatic glycosylation, elevation of protein kinase C, oxidative/carbonyl stress
polyol pathway
Hyperglycemia leads to an influx of glucose into cells, which can be metabolized by aldose reductase to sorbitol and fructose. These molecules can cause osmotic and oxidative stress leading to abnormal cellular function
non-enzymatic glycosylation
Glucose binds to proteins and nucleic acids forming advanced glycosylation end products (AGEs)- involved in nephropathy, vasculopathy and retinopathy. Interfere with basement membrane function, impair vasodilation, disrupt DNA function/repair
protein kinase C and diabetes
PKC leads to production of extracellular matrix proteins collagen and fibronectin in renal and vascular cells, causing basemnt membrane thickening. In endothelial cells promotes ICAM adhesion molecules, plasminogen inhibitor activator-1, VEGF and defective vasodilating NO